Navigation Links
National study will look at German-made heart pump for children needing heart transplants
Date:1/18/2008

HOUSTON Jan.18, 2008 --Texas Childrens Hospital has been named the national lead center for a 12-hospital, 36-month clinical trial of the German-manufactured pediatric heart pump called Berlin Heart EXCOR® Pediatric Ventricular Assist Device (VAD).

Charles D. Fraser, Jr., MD, chief of pediatric and congenital heart surgery at Texas Childrens and professor, Michael E. DeBakey Department of Surgery at Baylor College of Medicine, will serve as the National Principal Investigator for the Investigational Device Exemption prospective study. As NPI, Fraser will work in cooperation with 10 U. S. hospitals and two Canadian hospitals, in collecting and reporting data to the United States Food and Drug Administration on the safety and probable benefit of the pediatric heart pump. At the studys conclusion, Berlin Heart, Inc. will present those data to the FDA for consideration of approval of the EXCOR Pediatric VAD for use in the U.S.

The Berlin Heart holds a lot of promise for infants and children whose hearts are failing, said Fraser. Its extremely gratifying to be part of such a collaborative study involving the FDA and the other leading heart centers around the nation in exchanging information that will ultimately benefit many pediatric heart patients.

The Berlin Heart EXCOR Pediatric VAD, which comes in graduated sizes to fit a pediatric population from newborns to teens, is the only pediatric heart pump that provides medium-to-long-term mechanical circulatory support for infants and children awaiting heart transplantations. The device has been approved in Germany and Europe since 1992, but does not have FDA approval for use in the U. S.

The Berlin Heart is especially attractive as an option for circulatory support in babies and small children awaiting heart transplantation, said Fraser. A particular advantage is that children can get up, walk around and be kids again while they are recovering and waiting for a donor heart.

Along with Texas Children's Hospital, 11 hospitals will participate in the study: Arkansas Childrens Hospital, Little Rock; Boston Childrens Hospital; Childrens Hospital of Wisconsin in Milwaukee; Riley Childrens Hospital, Indianapolis; Mott Children Hospital, Ann Arbor; Lucille Packard Childrens at Stanford; St. Louis Childrens Hospital; Seattle Childrens Hospital; and Childrens Hospital at the University of Alabama at Birmingham. Stollery Childrens Hospital in Edmonton, and the Hospital for Sick Kids in Toronto are participating in Canada.

In addition to the IDE study, Texas Childrens Heart Center has been named the first Berlin Heart Reference and Training Center in the United States offering support to hospitals not participating in the study who seek to use the Berlin Heart for the first time. Dr. David Morales, pediatric cardiovascular surgeon at Texas Childrens and assistant professor, Michael E. DeBakey Department of Surgery at Baylor College of Medicine, will direct a training team comprised of cardiac surgeons, cardiologists, perfusionists, operating room nurses, ICU nurses, research nurses and a designated Berlin Heart Fellow. The team will hold periodic training sessions at Texas Children's, and they will also travel to other hospitals to provide instruction on-site.

We are delighted to have the exerienced and dedicated team from Texas Childrens Heart Center as our first Reference and Training Center in the U.S., said Robert H. Halfmann, MD, director clinical science at Berlin Heart GmbH, Germany. We are also pleased to work with Dr. Fraser as the NPI for the EXCOR Pediatric IDE trial, which is of great importance to us.

Between 2000 and 2007, prior to FDA approval to begin the study, pediatric hospitals in the U. S. used the Berlin Heart under the FDAs emergency or compassionate use regulations. Each time a physician wanted to implant the Berlin Heart in a child dying of heart failure, a special appeal had to be made to the FDA for approval on a case-by-case basis. If approved, the Berlin Heart had to be flown from Germany while the child waited, possibly losing precious time. Also, under prior FDA regulations, the device could not be stored in the U.S., but had to be flown back to Germany if it was not used. Now with the IDE study in place, participating centers may keep the device on hand for easier access for their patients with failing hearts.

BACKGROUND

Physicians in Arizona implanted the first Berlin Heart in the U.S. in 2000. Later, a 4-month-old baby who received the Berlin Heart at Stanford University received high-profile media coverage in August, 2004. The coverage piqued interest in the Berlin Heart among pediatric hospitals around the country. Texas Childrens Heart Center implanted its first Berlin Heart on September 27, 2005 in one of the smallest babies to ever receive the device. Currently, Texas Childrens has implanted seven Berlin Hearts in infants and young children between the ages of two months to 12 years. Based on his experience with the device, Fraser, a strong advocate of small devices for babies, began working with representatives of the Berlin Heart company in submitting evidence to the FDA. On May 9, 2007, the FDA granted a Conditional Investigational Device Exemption approval that allowed for a multi-center study or clinical trial to be set up.


'/>"/>

Contact: Carol Wittman
cwittma@texaschildrenshospital.org
832-824-7243, ext. 5695
Texas Children's Hospital
Source:Eurekalert

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Yakima Health Care Leader Tapped for Leadership Post at National Association
3. Virginia Tech Report Has National Importance
4. Donate Life America Dispels Myths About Organ & Tissue Donation Among Hispanics During National Hispanic Heritage Month
5. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. National Association of Subrogation Professionals (NASP), the Largest Insurance Subrogation Association in the World - Announced Today that Leslie Wiernik has Joined the Organization as Director of Education
8. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA National Model Detox Center
9. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
10. LCA Hails International Investigators Studying Lung Cancer
11. National Patient Safety Foundation Partners with Vocera Communications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events ... turn to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. ... tools for healthy coping following a traumatic event. , Trauma sufferers tend to feel ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016   Bay Area Lyme Foundation ... Dean Center for Tick Borne Illness , Harvard ... MIT Hacking Medicine, University of California, Berkeley, and ... the five finalists of Lyme Innovation , ... than 100 scientists, clinicians, researchers, entrepreneurs, and investors ...
(Date:6/24/2016)... ALEXANDRIA, Va. , June 24, 2016 ... a set of recommendations that would allow ... information (HCEI) with entities that make formulary and coverage ... determine the "value" of new medicines. The ... that does not appear on the drug label, a ...
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
Breaking Medicine Technology: